Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y
Cancer Res. 1977 Dec;37(12):4416-9.
Combined administration of a vaccine consisting of a small number (2 X 10(6)) of L1210 murine leukemic cells treated with glutaraldehyde and concanavalin A and a protein-bound polysaccharide preparation of Coriolus versicolor induced synergistic resistance to L1210 leukemia in BALB/c X DBA/2CrF1 mice. This effect was dependent on the dose and timing of the administration of the protein-bound polysaccharide preparation, being most effective at the time of or 1 day after the second vaccination. Induced resistance was not cross-reactive with P388 murine leukemia, indicating specificity of resistance. This immunopotentiation by the protein-bound polysaccharide did not occur when L1210 cells treated with glutaraldehyde, but not with concanavalin A, were used as a vaccine.
将由少量(2×10⁶)经戊二醛和伴刀豆球蛋白A处理的L1210小鼠白血病细胞组成的疫苗与云芝蛋白结合多糖制剂联合给药,可诱导BALB/c×DBA/2CrF1小鼠对L1210白血病产生协同抗性。这种效应取决于蛋白结合多糖制剂的给药剂量和时间,在第二次接种时或接种后1天最为有效。诱导的抗性与P388小鼠白血病无交叉反应,表明抗性具有特异性。当使用仅经戊二醛处理而未经伴刀豆球蛋白A处理的L1210细胞作为疫苗时,蛋白结合多糖不会产生这种免疫增强作用。